Loading stock data...

Syngene International Limited

NSE: SYNGENE BSE: SYNGENE

NSE
650.10 -0.55 (-0.08%)

Prev Close

650.65

Open Price

654.4

Volume

435,567

Today Low / High

647.05 / 657.55

52 WK Low / High

599.55 / 960.6

Range

618 - 683

BSE
650.30 -0.25 (-0.04%)

Prev Close

650.55

Open Price

652.8

Volume

4,122

Today Low / High

648.4 / 657

52 WK Low / High

598.55 / 960

Range

618 - 683

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 650.1 (target range: 618 - 683), reflecting a change of -0.55 (-0.08453085%). On the BSE, it is listed at 650.3 (target range: 618 - 683), showing a change of -0.25 (-0.03842902%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

31 Oct 654.40 -0.66%
30 Oct 657.40 -1.03%
29 Oct 657.50 0.27%
28 Oct 658.00 -0.08%
27 Oct 662.00 -0.24%
24 Oct 666.15 -0.95%
23 Oct 644.00 2.68%
21 Oct 643.90 -0.32%
20 Oct 639.95 0.62%
17 Oct 644.40 -0.89%
16 Oct 628.50 1.89%
15 Oct 625.55 0.41%
14 Oct 634.00 -1.32%
13 Oct 650.00 -2.48%
10 Oct 636.45 2.33%
09 Oct 630.00 1.37%
08 Oct 632.40 -0.28%
07 Oct 634.50 -0.28%
06 Oct 635.95 -0.23%
03 Oct 631.00 0.71%

Syngene International Limited Graph

Syngene International Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Syngene International Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 650.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 650.30 656.80 591.12 - 722.48
663.31 530.64 - 795.97
669.81 468.87 - 870.75
Bearish Scenario 650.30 643.80 579.42 - 708.18
637.29 509.84 - 764.75
630.79 441.55 - 820.03

Overview of Syngene International Limited

ISIN

INE398R01022

Industry

Biotechnology

Vol.Avg

638,807

Market Cap

260,939,987,388

Last Dividend

1.25

Official Website

Visit Website

IPO Date

2015-08-11

DCF Diff

-1,243.79

DCF

1,911

Financial Ratios Every Investor Needs

Stock Dividend of SYNGENE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-06-27 June 27, 25 1.25 1.25 2025-06-27 2025-08-22
2024-06-28 June 28, 24 1.25 1.25 2024-06-28 2024-08-05
2023-06-30 June 30, 23 1.25 1.25 2023-06-30 2023-08-07
2022-06-30 June 30, 22 1 1 2022-07-01 2022-08-01
2019-07-16 July 16, 19 0.5 0.5 2019-07-17 2019-07-31 2019-04-24

Stock Rating Details for SYNGENE

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 5 Strong Buy
ROE Score 3 Neutral
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 3,642.40 Cr 1,201.40 Cr 2,441.00 Cr 0.6702 14.80 Cr 1,013.50 Cr 1,393.40 Cr 496.20 Cr 12.35 991.20 Cr 0.1362
2024-03-31 3,488.60 Cr 1,138.60 Cr 2,350.00 Cr 0.6736 14.40 Cr 923.00 Cr 1,395.30 Cr 510.00 Cr 12.71 1,030.10 Cr 0.1462
2023-03-31 3,192.90 Cr 1,036.80 Cr 2,156.10 Cr 0.6753 10.00 Cr 878.80 Cr 1,252.20 Cr 464.40 Cr 11.59 959.30 Cr 0.1454
2022-03-31 2,604.20 Cr 892.10 Cr 1,712.10 Cr 0.6574 4.90 Cr 741.40 Cr 956.80 Cr 395.80 Cr 9.94 725.60 Cr 0.1520
2021-03-31 2,184.30 Cr 656.60 Cr 1,527.70 Cr 0.6994 8.50 Cr 676.20 Cr 840.00 Cr 404.90 Cr 10.18 644.30 Cr 0.1854

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 367.10 Cr 6,795.90 Cr 2,069.10 Cr 4,726.8000 Cr 577.90 Cr 210.80 Cr 155.50 Cr 4,003.20 Cr 0.00 Cr 218.80 Cr 242.90 Cr 1,396.4000 Cr
2024-03-31 85.60 Cr 6,151.60 Cr 1,893.80 Cr 4,257.7000 Cr 555.20 Cr 469.60 Cr 238.50 Cr 3,625.10 Cr 553.80 Cr 243.80 Cr 260.70 Cr 1,144.2000 Cr
2023-03-31 89.50 Cr 5,831.00 Cr 2,213.00 Cr 3,618.0000 Cr 815.20 Cr 725.70 Cr 332.80 Cr 2,777.20 Cr 605.70 Cr 256.40 Cr 351.30 Cr 1,188.2000 Cr
2022-03-31 261.00 Cr 5,563.80 Cr 2,266.20 Cr 3,297.6000 Cr 1,021.60 Cr 760.60 Cr 179.40 Cr 2,698.40 Cr 477.40 Cr 252.80 Cr 433.70 Cr 1,228.9000 Cr
2021-03-31 322.00 Cr 4,883.20 Cr 2,061.80 Cr 2,821.4000 Cr 892.90 Cr 570.90 Cr 59.60 Cr 2,389.90 Cr 417.70 Cr 236.80 Cr 467.50 Cr 1,133.0000 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 1,167.6000 Cr -744.7000 Cr -141.8000 Cr 397.5000 Cr 281.4000 Cr 367.1000 Cr -760.3000 Cr 496.2000 Cr -24.6000 Cr -50.3000 Cr 74.3000 Cr
2024-03-31 1,042.1000 Cr -495.6000 Cr -551.5000 Cr 550.1000 Cr -3.8000 Cr 85.7000 Cr -492.0000 Cr 510.0000 Cr -435.6000 Cr -50.3000 Cr 114.6000 Cr
2023-03-31 838.4000 Cr -688.2000 Cr -340.2000 Cr 305.3000 Cr -186.9000 Cr 72.1000 Cr -533.1000 Cr 473.0000 Cr -258.1000 Cr -40.1000 Cr -153.4000 Cr
2022-03-31 580.6000 Cr -611.5000 Cr -31.3000 Cr 105.1000 Cr -61.5000 Cr 261.8000 Cr -475.5000 Cr 395.8000 Cr -5.8000 Cr 0.0000 Cr -119.8000 Cr
2021-03-31 701.2000 Cr -628.1000 Cr 58.0000 Cr 254.7000 Cr 130.3000 Cr 323.3000 Cr -446.5000 Cr 404.9000 Cr 89.2000 Cr 0.0000 Cr -34.4000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 874.50 Cr 217.60 Cr 656.90 Cr 0.7512 395.20 Cr 86.70 Cr 2.16 194.30 Cr 0.0991
2025-03-31 1,018.00 Cr 493.90 Cr 524.10 Cr 0.5148 207.40 Cr 183.30 Cr 4.56 339.30 Cr 0.1801
2024-12-31 943.70 Cr 237.40 Cr 706.30 Cr 0.7484 456.80 Cr 131.10 Cr 3.27 269.03 Cr 0.1389
2024-09-30 891.00 Cr 236.60 Cr 654.40 Cr 0.7345 402.90 Cr 106.10 Cr 2.64 238.55 Cr 0.1191
2024-06-30 789.70 Cr 233.50 Cr 556.20 Cr 0.7043 326.30 Cr 75.70 Cr 1.89 162.03 Cr 0.0959

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 233.80 Cr 928.70 Cr 1,162.50 Cr 559.40 Cr 182.50 Cr 2,165.90 Cr 3,957.40 Cr 6,674.40 Cr 1,828.10 Cr
2025-03-31 367.10 Cr 1,030.40 Cr 1,397.30 Cr 551.20 Cr 155.50 Cr 2,287.30 Cr 4,003.20 Cr 6,795.90 Cr 2,069.10 Cr
2024-12-31 183.00 Cr 817.70 Cr 1,000.70 Cr 535.10 Cr 172.50 Cr 1,882.20 Cr 0.00 Cr 6,086.70 Cr 1,604.70 Cr
2024-09-30 220.60 Cr 802.70 Cr 1,023.30 Cr 483.90 Cr 170.50 Cr 1,877.10 Cr 3,697.20 Cr 6,136.00 Cr 1,740.50 Cr
2024-06-30 -1,076.70 Cr 2,153.40 Cr 1,076.70 Cr 400.60 Cr 198.50 Cr 1,076.70 Cr 3,660.80 Cr 6,111.50 Cr 1,742.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 86.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 183.30 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 131.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 106.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 75.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2019-06-11 June 11, 19 2:1

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹372.10 ₹496,781,777,367.00 ₹2,111,938.00
Anthem Biosciences Ltd. ANTHEM ₹710.10 ₹398,799,297,215.00 ₹343,569.00
Piramal Pharma Limited PPLPHARMA ₹199.63 ₹264,339,882,238.00 ₹1,739,695.00
Syngene International Limited SYNGENE ₹650.10 ₹260,939,987,388.00 ₹435,567.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,854.10 ₹212,341,202,986.00 ₹120,757.00
Concord Biotech Limited CONCORDBIO ₹1,443.80 ₹151,044,875,335.00 ₹41,125.00
Blue Jet Healthcare Limited BLUEJET ₹656.40 ₹113,862,704,970.00 ₹212,670.00
Jubilant Ingrevia Limited JUBLINGREA ₹689.95 ₹108,993,347,159.00 ₹251,771.00
Supriya Lifescience Limited SUPRIYA ₹776.90 ₹62,527,087,320.00 ₹1,252,724.00
Zota Health Care Limited ZOTA ₹1,511.00 ₹45,832,641,705.00 ₹42,257.00
Dishman Carbogen Amcis Limited DCAL ₹291.80 ₹45,749,307,121.00 ₹350,194.00

Key Executives

Head of Legal, Company Secretary & Compliance Officer
Ms. Priyadarshini Mahapatra C.S.

Gender: female

Year Born:

Head of IT
Mr. Ajit Manocha

Gender: male

Year Born:

Head of Investor Relations
Krishnan G

Gender: Not Specified

Year Born:

Head of Corporate Communications
Mr. Sandeep Nair

Gender: male

Year Born:

Chief Financial Officer
Mr. Deepak Jain

Gender: male

Year Born:

Chief Scientific Officer
Dr. Jayashree Aiyar Ph.D.

Gender: Not Specified

Year Born:

Head of Pharmaceutical & Biopharmaceutical Development
Dr. Dhananjay Patankar

Gender: Not Specified

Year Born:

Head of Formulations Development
Mr. Purushottam Shashikant Singnurkar

Gender: male

Year Born:

Chief Executive Officer & MD
Mr. Peter James Jonathan Bains

Gender: male

Year Born: 1957

Chief Human Resources Officer
Mr. Andrew Webster

Gender: male

Year Born:

FAQs about Syngene International Limited

Who is the CEO of the company?

The CEO is Peter James Jonathan Bains.

What is the current market price of the stock?

The current price is ₹650.10.

What is the 52-week price range?

The range is ₹599.55-960.6.

What is the market capitalization of the company?

The market capitalization is ₹26,094.00 crores.

What is the dividend yield?

The dividend yield is 0.19%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 51.45.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Syngene International Limited (ISIN: INE398R01022) is a leading Biotechnology in India. With a market capitalization of ₹26,094.00 crores and an average daily volume of 638,807 shares, it operates in the Biotechnology. The company last declared a dividend of ₹1.25.